On the public citation graph

Neglected Disease Research and Development: How Much Are We Really Spending?

https://doi.org/10.1371/journal.pmed.1000030
0 signed · 223 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1016/0169-4758(89)90254-8openalex-snapshot
UNDP/World Bank/WHO special programme for research and training in tropical diseases (TDR)
inferredcites →https://doi.org/10.1016/b0-12-227055-x/01300-6openalex-snapshot
WORLD HEALTH ORGANIZATION
inferredcites →https://doi.org/10.1056/nejmra064142openalex-snapshot
Control of Neglected Tropical Diseases
inferredcites →https://doi.org/10.1590/s1020-49892002000800017openalex-snapshot
Macroeconomics and health: investing in health for economic development

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.1824392openalex-extracted
Where Have All the Donors Gone? Scarce Donor Funding for Non-Communicable Diseases
inferred← citeshttps://doi.org/10.2139/ssrn.2003947openalex-extracted
Ethical and Economic Perspectives on Global Health Interventions
inferred← citeshttps://doi.org/10.2139/ssrn.2744686openalex-extracted
Explaining Variation in Medical Innovation: The Case of Vaccines, and the HIV AIDS Effort
inferred← citeshttps://doi.org/10.2139/ssrn.4092494openalex-extracted
Big Pharma and Monopoly Capitalism: A Long-Term View
inferred← citeshttps://doi.org/10.1001/virtualmentor.2009.11.7.pfor1-0907openalex-snapshot
Patents, Pricing, and Access to Essential Medicines in Developing Countries
inferred← citeshttps://doi.org/10.1002/9781118274408.ch11openalex-snapshot
Repurposing Drugs for Tropical Diseases: Case Studies and Open‐Source Screening Initiatives
inferred← citeshttps://doi.org/10.1002/9781118509623.ch11openalex-snapshot
Ethical and Economic Perspectives on Global Health Interventions
inferred← citeshttps://doi.org/10.1002/9781118532331.ch1openalex-snapshot
Discovery of New Medicines
inferred← citeshttps://doi.org/10.1002/ddr.20453openalex-snapshot
Drugs against leishmaniasis: Overview of market needs and pipeline
inferred← citeshttps://doi.org/10.1002/hec.2909openalex-snapshot
FUNDING HIV‐VACCINE RESEARCH IN DEVELOPING COUNTRIES—WHAT IS WRONG WITH IAVI's RECOMMENDATION?
inferred← citeshttps://doi.org/10.1002/jid.2858openalex-snapshot
A GROUNDED THEORY STUDY OF THE ESTABLISHMENT OF PUBLIC–PRIVATE ALLIANCES IN OFFICIAL DEVELOPMENT ASSISTANCE PROGRAMMES
inferred← citeshttps://doi.org/10.1007/7355_2016_5openalex-snapshot
Neglected Tropical Bacterial Diseases
inferred← citeshttps://doi.org/10.1007/978-1-4419-6920-0_4openalex-snapshot
Pneumonia
inferred← citeshttps://doi.org/10.1007/978-1-4419-6920-0_6openalex-snapshot
Diarrheal Diseases
inferred← citeshttps://doi.org/10.1007/978-1-4614-9062-3_3openalex-snapshot
Policies and Practices to Enhance Multi-sectorial Collaborations and Commercialization of Regenerative Medicine
inferred← citeshttps://doi.org/10.1007/978-3-031-53901-5_14openalex-snapshot
Soil-Transmitted Helminthiasis
inferred← citeshttps://doi.org/10.1007/978-3-319-25471-5_12openalex-snapshot
Soil-Transmitted Helminthiasis
inferred← citeshttps://doi.org/10.1007/978-981-10-8417-1_9openalex-snapshot
CADD Studies Applied to Secondary Metabolites in the Anticancer Drug Research
inferred← citeshttps://doi.org/10.1007/s10096-011-1515-4openalex-snapshot
Current status of food-borne trematode infections
inferred← citeshttps://doi.org/10.1007/s11192-014-1252-4openalex-snapshot
No free lunches in nature? An analysis of the regional distribution of the affiliations of Nature publications
inferred← citeshttps://doi.org/10.1007/s11192-024-04980-xopenalex-snapshot
Priorities of health research in India: evidence of misalignment between research outputs and disease burden
inferred← citeshttps://doi.org/10.1007/s11306-019-1520-7openalex-snapshot
Untargeted LC–MS metabolomic studies of Asteraceae species to discover inhibitors of Leishmania major dihydroorotate dehydrogenase
inferred← citeshttps://doi.org/10.1007/s11568-009-9131-4openalex-snapshot
Germs, genomics and global public health
inferred← citeshttps://doi.org/10.1007/s40797-024-00279-1openalex-snapshot
Attributes and Trends of Rentified Capitalism
inferred← citeshttps://doi.org/10.1007/s43253-025-00156-2openalex-snapshot
What financialisation is doing to access to healthcare: price and value of medicines in financial capitalism
inferred← citeshttps://doi.org/10.1016/b978-0-12-816125-8.00021-3openalex-snapshot
In Silico Modeling of FDA-Approved Drugs for Discovery of Therapies Against Neglected Diseases: A Drug Repurposing Approach
inferred← citeshttps://doi.org/10.1016/b978-1-4377-0134-0.10004-6openalex-snapshot
Global Neonatal Health
inferred← citeshttps://doi.org/10.1016/b978-1-60805-865-5.50002-2openalex-snapshot
Knowledge-Based Drug Repurposing: A Rational Approach Towards the Identification of Novel Medical Applications of Known Drugs
inferred← citeshttps://doi.org/10.1016/bs.apar.2015.01.002openalex-snapshot
Economic and Financial Evaluation of Neglected Tropical Diseases
inferred← citeshttps://doi.org/10.1016/bs.apcsb.2020.04.001openalex-snapshot
In silico tools to study molecular targets of neglected diseases: inhibition of TcSir2rp3, an epigenetic enzyme of Trypanosoma cruzi
inferred← citeshttps://doi.org/10.1016/j.actatropica.2009.08.015openalex-snapshot
The 10/90 gap in sub-Saharan Africa: Resolving inequities in health research
inferred← citeshttps://doi.org/10.1016/j.actatropica.2009.10.023openalex-snapshot
Specific chemotherapy of Chagas disease: Relevance, current limitations and new approaches
inferred← citeshttps://doi.org/10.1016/j.actatropica.2010.08.020openalex-snapshot
From innovation to application: Social–ecological context, diagnostics, drugs and integrated control of schistosomiasis
inferred← citeshttps://doi.org/10.1016/j.actatropica.2016.10.004openalex-snapshot
How do you get the Rose Bengal Test at the point-of-care to diagnose brucellosis in Africa? The importance of a systems approach
inferred← citeshttps://doi.org/10.1016/j.bushor.2010.05.001openalex-snapshot
Better marketing to developing countries: Why and how
inferred← citeshttps://doi.org/10.1016/j.clay.2013.12.029openalex-snapshot
Layered double hydroxides (LDHs) as carrier of antimony aimed for improving leishmaniasis chemotherapy
inferred← citeshttps://doi.org/10.1016/j.clinmicnews.2009.07.004openalex-snapshot
Buruli Ulcer (Mycobacterium ulcerans Infection): a Re-emerging Disease
inferred← citeshttps://doi.org/10.1016/j.clinthera.2014.05.004openalex-snapshot
Measuring Progress in Neglected Disease Drug Development
inferred← citeshttps://doi.org/10.1016/j.diagmicrobio.2011.06.011openalex-snapshot
Synthesis, cytotoxicity, and in vitro antileishmanial activity of mono-t-butyloxycarbonyl-protected diamines
inferred← citeshttps://doi.org/10.1016/j.diagmicrobio.2012.11.018openalex-snapshot
An alternative in vitro drug screening test using Leishmania amazonensis transfected with red fluorescent protein
inferred← citeshttps://doi.org/10.1016/j.drudis.2010.08.010openalex-snapshot
When pharmaceutical companies publish large datasets: an abundance of riches or fool's gold?
inferred← citeshttps://doi.org/10.1016/j.drudis.2012.05.014openalex-snapshot
WITHDRAWN: Enabling infrastructure for global health product development
inferred← citeshttps://doi.org/10.1016/j.drudis.2012.06.006openalex-snapshot
WITHDRAWN: Maintaining the momentum of antitubercular drug discovery
inferred← citeshttps://doi.org/10.1016/j.drudis.2012.06.012openalex-snapshot
Promoting global health: utilizing WHO to integrate public health, innovation and intellectual property
inferred← citeshttps://doi.org/10.1016/j.ejmech.2018.08.033openalex-snapshot
Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase
inferred← citeshttps://doi.org/10.1016/j.gheart.2013.08.009openalex-snapshot
The Importance of Awareness and Education in Prevention and Control of RHD
inferred← citeshttps://doi.org/10.1016/j.idc.2011.05.007openalex-snapshot
Global Health: Neglected Diseases and Access to Medicines
inferred← citeshttps://doi.org/10.1016/j.ijid.2010.10.007openalex-snapshot
Diagnostics are central for a truly holistic approach against intestinal parasitic diseases
inferred← citeshttps://doi.org/10.1016/j.inhe.2009.08.004openalex-snapshot
Official development assistance for health–how neglected are neglected tropical diseases? An analysis of health financing
inferred← citeshttps://doi.org/10.1016/j.inhe.2010.04.002openalex-snapshot
The role of Product Development Partnerships in research and development for neglected diseases
inferred← citeshttps://doi.org/10.1016/j.joi.2012.10.004openalex-snapshot
Scientometrics reveals funding priorities in medical research policy
inferred← citeshttps://doi.org/10.1016/j.jpeds.2026.115103openalex-snapshot
Breaking the Triple Barrier to Equitable and Inclusive Pediatric Research and Innovation
inferred← citeshttps://doi.org/10.1016/j.jprot.2011.03.029openalex-snapshot
Proteomics of foodborne trematodes
inferred← citeshttps://doi.org/10.1016/j.nbt.2010.02.003openalex-snapshot
The challenge of Chagas’ disease: Has the human pathogen, Trypanosoma cruzi, learned how to modulate signaling events to subvert host cells?
inferred← citeshttps://doi.org/10.1016/j.phytol.2016.10.009openalex-snapshot
Cognate and cognitive ecopharmacognosy — in an anthropogenic era
inferred← citeshttps://doi.org/10.1016/j.provac.2010.07.003openalex-snapshot
Aims and role of Novartis Vaccines Institute for Global Health (NVGH)
inferred← citeshttps://doi.org/10.1016/j.pt.2010.06.002openalex-snapshot
Bringing neglected tropical diseases into the spotlight
inferred← citeshttps://doi.org/10.1016/j.pt.2017.10.001openalex-snapshot
The Deadly Dance of B Cells with Trypanosomatids
inferred← citeshttps://doi.org/10.1016/j.respol.2012.05.013openalex-snapshot
Mission-oriented biomedical research at the NIH
inferred← citeshttps://doi.org/10.1016/j.socscimed.2011.05.043openalex-snapshot
Apparent displacement of global health funding priorities: Time for some difficult decisions? A commentary on Lordan, Tang and Carmignani
inferred← citeshttps://doi.org/10.1016/j.strueco.2023.01.004openalex-snapshot
Big Pharma and monopoly capitalism: A long-term view
inferred← citeshttps://doi.org/10.1016/j.worlddev.2011.05.017openalex-snapshot
Can Public–Private Partnerships Leverage Private Investment in Agricultural Value Chains in Africa? A Preliminary Review
inferred← citeshttps://doi.org/10.1016/j.yrtph.2024.105626openalex-snapshot
Biosimilars production in Africa opportunities & challenges
inferred← citeshttps://doi.org/10.1016/s0065-308x(10)72001-7openalex-snapshot
Important Helminth Infections in Southeast Asia
inferred← citeshttps://doi.org/10.1016/s0140-6736(09)60571-7openalex-snapshot
The Bill & Melinda Gates Foundation's grant-making programme for global health
inferred← citeshttps://doi.org/10.1016/s0140-6736(09)60886-2openalex-snapshot
Accelerating the health impact of the Gates Foundation
inferred← citeshttps://doi.org/10.1016/s0140-6736(09)61608-1openalex-snapshot
The deadly toll of S pneumoniae and H influenzae type b
inferred← citeshttps://doi.org/10.1016/s0140-6736(09)61749-9openalex-snapshot
Programmes, partnerships, and governance for elimination and control of neglected tropical diseases
inferred← citeshttps://doi.org/10.1016/s0140-6736(10)60393-5openalex-snapshot
New vaccines for tuberculosis
inferred← citeshttps://doi.org/10.1016/s0140-6736(10)60669-1openalex-snapshot
Introduction of European priority review vouchers to encourage development of new medicines for neglected diseases
inferred← citeshttps://doi.org/10.1016/s0140-6736(18)30999-1openalex-snapshot
Acute rheumatic fever
inferred← citeshttps://doi.org/10.1016/s1473-3099(10)70050-5openalex-snapshot
Funding for research and development and the financial crisis
inferred← citeshttps://doi.org/10.1016/s1473-3099(10)70191-2openalex-snapshot
Global burden and investment for neglected diseases?
inferred← citeshttps://doi.org/10.1016/s1473-3099(12)70289-xopenalex-snapshot
Mapping the terrain of investment in global infectious diseases
inferred← citeshttps://doi.org/10.1016/s1473-3099(21)00585-5openalex-snapshot
Using big data and mobile health to manage diarrhoeal disease in children in low-income and middle-income countries: societal barriers and ethical implications
inferred← citeshttps://doi.org/10.1017/cbo9780511984792.025openalex-snapshot
Global health research: changing the agenda
inferred← citeshttps://doi.org/10.1017/s0031182011000023openalex-snapshot
Antiparasitic drugs for paediatrics: systematic review, formulations, pharmacokinetics, safety, efficacy and implications for control
inferred← citeshttps://doi.org/10.1017/s0031182012000029openalex-snapshot
Schistosomiasis in infants and pre-school-aged children in sub-Saharan Africa: implication for control
inferred← citeshttps://doi.org/10.1021/acschembio.5b00308openalex-snapshot
Genome-Directed Lead Discovery: Biosynthesis, Structure Elucidation, and Biological Evaluation of Two Families of Polyene Macrolactams against Trypanosoma brucei
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.7b00011openalex-snapshot
Antiparasitic Lead Discovery: Toward Optimization of a Chemotype with Activity Against Multiple Protozoan Parasites
inferred← citeshttps://doi.org/10.1038/457772aopenalex-snapshot
Neglected disease boost
inferred← citeshttps://doi.org/10.1038/clpt.2009.51openalex-snapshot
The Global Portfolio of New Antimalarial Medicines Under Development
inferred← citeshttps://doi.org/10.1038/clpt.2009.54openalex-snapshot
Global Challenges for Clinical Pharmacology in the Developing World
inferred← citeshttps://doi.org/10.1038/mi.2009.19openalex-snapshot
Science funding in low- and middle-income countries: the example of vaccine research
inferred← citeshttps://doi.org/10.1038/nprot.2017.067openalex-snapshot
The Mini-FLOTAC technique for the diagnosis of helminth and protozoan infections in humans and animals
inferred← citeshttps://doi.org/10.1038/nrdp.2015.84openalex-snapshot
Acute rheumatic fever and rheumatic heart disease
inferred← citeshttps://doi.org/10.1038/nrmicro2273openalex-snapshot
Closing the GAPP on pneumonia
inferred← citeshttps://doi.org/10.1039/9781849733496-00134openalex-snapshot
Drugs for Kinetoplastid Diseases – Current Situation and Challenges
inferred← citeshttps://doi.org/10.1039/c2md20019hopenalex-snapshot
Preliminary in vitro evaluation of N′-(benzofuroxan-5-yl)methylene benzohydrazide derivatives as potential anti-Trypanosoma cruzi agents
inferred← citeshttps://doi.org/10.1055/s-0043-113249openalex-snapshot
Möglichkeiten der universitären Einflussnahme auf die globale Preisgestaltung von Medikamenten
inferred← citeshttps://doi.org/10.1057/9781137456038_10openalex-snapshot
The Influence of Intellectual Property Protection on Drug Development for Neglected Tropical Diseases
inferred← citeshttps://doi.org/10.1080/03085147.2018.1528075openalex-snapshot
The deferred promise of radical cure: pharmaceutical conjugations of malaria in the global health era
inferred← citeshttps://doi.org/10.1080/17441692.2012.699535openalex-snapshot
Removing the neglect from neglected tropical diseases: The Rwandan experience 2008–2010
inferred← citeshttps://doi.org/10.1080/20786204.2013.10874373openalex-snapshot
Utility of kangaroo mother care in preterm and low birthweight infants
inferred← citeshttps://doi.org/10.1089/ars.2011.4404openalex-snapshot
Peroxiredoxins in Parasites
inferred← citeshttps://doi.org/10.1093/aje/kwp316openalex-snapshot
Editorial: Breathing New Life Into Pneumonia Epidemiology
inferred← citeshttps://doi.org/10.1093/heapol/czq030openalex-snapshot
The relationships between foreign aid, HIV and government health spending
inferred← citeshttps://doi.org/10.1093/icc/dtx016openalex-snapshot
Variation in the dynamics and performance of industrial innovation: what can we learn from vaccines and HIV vaccines?
inferred← citeshttps://doi.org/10.1101/161901openalex-snapshot
Agrochemical pollution increases risk of human exposure to schistosome parasites
inferred← citeshttps://doi.org/10.1108/s0742-3322(2013)0000030006openalex-snapshot
Building Joint Value: Ecosystem Support for Global Health Innovations
inferred← citeshttps://doi.org/10.1111/1365-2664.14087openalex-snapshot
Reducing disease and producing food: Effects of 13 agrochemicals on snail biomass and human schistosomes
inferred← citeshttps://doi.org/10.1111/cbdd.12123openalex-snapshot
Synthesis, Cytotoxicity and In Vitro Antileishmanial Activity of Naphthothiazoles
inferred← citeshttps://doi.org/10.1111/dewb.12016openalex-snapshot
Disease Control Priorities for Neglected Tropical Diseases: Lessons from Priority Ranking Based on the Quality of Evidence, Cost Effectiveness, Severity of Disease, Catastrophic Health Expenditures, and Loss of Productivity
inferred← citeshttps://doi.org/10.1111/ecca.12012openalex-snapshot
Appropriate Health R&D and Intellectual Property Rights Reform in Developing Countries
inferred← citeshttps://doi.org/10.1111/ele.12295openalex-snapshot
Community ecology theory predicts the effects of agrochemical mixtures on aquatic biodiversity and ecosystem properties
inferred← citeshttps://doi.org/10.1111/geoj.12061openalex-snapshot
(Global) health geography and the post‐2015 development agenda
inferred← citeshttps://doi.org/10.1111/j.1365-2796.2010.02216.xopenalex-snapshot
Novel tuberculosis vaccination strategies based on understanding the immune response
inferred← citeshttps://doi.org/10.1111/j.1365-3156.2012.03027.xopenalex-snapshot
Health research in Africa: getting priorities right
inferred← citeshttps://doi.org/10.1111/j.1758-5899.2011.00110.xopenalex-snapshot
Promising Trends in Access to Medicines
inferred← citeshttps://doi.org/10.1111/tmi.13478openalex-snapshot
Neglected tropical diseases in Brazil: lack of correlation between disease burden, research funding and output
inferred← citeshttps://doi.org/10.1126/science.324.5923.37bopenalex-snapshot
Rheumatic Fever: Neglected Again
inferred← citeshttps://doi.org/10.1126/scitranslmed.3003490openalex-snapshot
Recalibrating Intellectual Property Rights to Enhance Translational Research Collaborations
inferred← citeshttps://doi.org/10.1128/msphere.00078-18openalex-snapshot
Aggregative Adherence and Intestinal Colonization by Enteroaggregative Escherichia coli Are Produced by Interactions among Multiple Surface Factors
inferred← citeshttps://doi.org/10.1136/archdischild-2013-304765openalex-snapshot
Treating diarrhoeal disease in children under five: the global picture
inferred← citeshttps://doi.org/10.1142/9781848169555_0003openalex-snapshot
The Impact of the Changing Social, Political and Economic Environment on Medical Science
inferred← citeshttps://doi.org/10.1146/annurev-animal-062922-060125openalex-snapshot
Domestic Animals as Potential Reservoirs of Zoonotic Viral Diseases
inferred← citeshttps://doi.org/10.1155/2013/961783openalex-snapshot
Cytotoxicity andIn VitroAntileishmanial Activity of Antimony (V), Bismuth (V), and Tin (IV) Complexes of Lapachol
inferred← citeshttps://doi.org/10.1155/2017/4765719openalex-snapshot
R&D in Vaccines Targeting Neglected Diseases: An Exploratory Case Study Considering Funding for Preventive Tuberculosis Vaccine Development from 2007 to 2014
inferred← citeshttps://doi.org/10.11604/pamj.2013.16.10.2318openalex-snapshot
Research priority setting for health policy and health systems strengthening in Nigeria: the policymakers’ and stakeholders’ perspective and involvement
inferred← citeshttps://doi.org/10.11606/t.60.2018.tde-11102018-082601openalex-snapshot
Triagem de inibidores da enzima DHODH de Leishmania major em Asteraceae: estudos metabolômicos e da relação estrutura-atividade quantitativa (QSAR)
inferred← citeshttps://doi.org/10.1162/rest_a_00214openalex-snapshot
Investments in Pharmaceuticals Before and After TRIPS
inferred← citeshttps://doi.org/10.1177/0011392115590093openalex-snapshot
The ‘empty choice’: A sociological examination of choosing medical research participation in resource-limited Sub-Saharan Africa
inferred← citeshttps://doi.org/10.1177/0022034511402015openalex-snapshot
Global Oral Health Inequalities
inferred← citeshttps://doi.org/10.1177/0971721816682799openalex-snapshot
Getting Undone Technology Done: Global Techno-assemblage and the Value Chain of Invention
inferred← citeshttps://doi.org/10.1179/107735211807523972openalex-snapshot
Gets AIDS and Survive? The "Perverse" Effects of Aid: Addressing the Social and Environmental Determinants of Health, Promoting Sustainable Primary Care, and Rethinking Global Health Aid
inferred← citeshttps://doi.org/10.1186/1472-6939-14-s1-s7openalex-snapshot
Maintaining respect and fairness in the usage of stored shared specimens
inferred← citeshttps://doi.org/10.1186/1472-6939-15-49openalex-snapshot
Linking international clinical research with stateless populations to justice in global health
inferred← citeshttps://doi.org/10.1186/1472-6963-11-312openalex-snapshot
Expert Delphi survey on research and development into drugs for neglected diseases
inferred← citeshttps://doi.org/10.1186/1472-698x-10-8openalex-snapshot
Human-animal chimeras for vaccine development: an endangered species or opportunity for the developing world?
inferred← citeshttps://doi.org/10.1186/1475-2875-11-341openalex-snapshot
Finding parasites and finding challenges: improved diagnostic access and trends in reported malaria and anti-malarial drug use in Livingstone district, Zambia
inferred← citeshttps://doi.org/10.1186/1478-4505-11-10openalex-snapshot
Determining quantitative targets for public funding of tuberculosis research and development
inferred← citeshttps://doi.org/10.1186/1478-4505-12-68openalex-snapshot
Needs assessment to strengthen capacity in water and sanitation research in Africa: experiences of the African SNOWS consortium
inferred← citeshttps://doi.org/10.1186/1478-4505-8-36openalex-snapshot
A checklist for health research priority setting: nine common themes of good practice
inferred← citeshttps://doi.org/10.1186/1478-4505-9-12openalex-snapshot
Aid alignment for global health research: the role of HIROs
inferred← citeshttps://doi.org/10.1186/1478-4505-9-2openalex-snapshot
Social sciences research in neglected tropical diseases 3: Investment in social science research in neglected diseases of poverty: a case study of Bill and Melinda Gates Foundation
inferred← citeshttps://doi.org/10.1186/1756-3305-4-53openalex-snapshot
Major prospects for exploring canine vector borne diseases and novel intervention methods using 'omic technologies
inferred← citeshttps://doi.org/10.1186/s12961-015-0010-2openalex-snapshot
Assessing the implementation and influence of policies that support research and innovation systems for health: the cases of Mozambique, Senegal, and Tanzania
inferred← citeshttps://doi.org/10.1186/s12961-019-0459-5openalex-snapshot
Using research priority-setting to guide bridging the implementation gap in countries – a case study of the Uganda newborn research priorities in the SDG era
inferred← citeshttps://doi.org/10.1186/s12992-014-0072-xopenalex-snapshot
A systematic mapping of funders of maternal health intervention research 2000-2012
inferred← citeshttps://doi.org/10.1186/s40249-018-0444-1openalex-snapshot
Innovation in neglected tropical disease drug discovery and development
inferred← citeshttps://doi.org/10.1186/s40575-019-0069-0openalex-snapshot
Miniature Schnauzers under primary veterinary care in the UK in 2013: demography, mortality and disorders
inferred← citeshttps://doi.org/10.1186/s41182-026-00951-5openalex-snapshot
The pharmaceutical industry’s multifaceted role in neglected tropical disease control: from market failure to global health innovation
inferred← citeshttps://doi.org/10.1201/ebk1439835272-3openalex-snapshot
Drug Discovery for Neglected Diseases of the Developing World
inferred← citeshttps://doi.org/10.1201/ebk1439835272-6openalex-snapshot
Drug Discovery for Neglected Diseases of the Developing World
inferred← citeshttps://doi.org/10.1371/journal.pmed.1000190openalex-snapshot
A “One Health” Approach to Address Emerging Zoonoses: The HALI Project in Tanzania
inferred← citeshttps://doi.org/10.1371/journal.pmed.1000308openalex-snapshot
Evidence-Based Priority Setting for Health Care and Research: Tools to Support Policy in Maternal, Neonatal, and Child Health in Africa
inferred← citeshttps://doi.org/10.1371/journal.pmed.1000330openalex-snapshot
Are Drug Companies Living Up to Their Human Rights Responsibilities? The Perspective of the Former United Nations Special Rapporteur (2002-2008)
inferred← citeshttps://doi.org/10.1371/journal.pmed.1000389openalex-snapshot
Setting Research Priorities to Reduce Almost One Million Deaths from Birth Asphyxia by 2015
inferred← citeshttps://doi.org/10.1371/journal.pmed.1001099openalex-snapshot
Setting Research Priorities to Reduce Global Mortality from Childhood Pneumonia by 2015
inferred← citeshttps://doi.org/10.1371/journal.pntd.0000484openalex-snapshot
New, Improved Treatments for Chagas Disease: From the R&D Pipeline to the Patients
inferred← citeshttps://doi.org/10.1371/journal.pntd.0000501openalex-snapshot
Co-authorship Network Analysis: A Powerful Tool for Strategic Planning of Research, Development and Capacity Building Programs on Neglected Diseases
inferred← citeshttps://doi.org/10.1371/journal.pntd.0000635openalex-snapshot
The Global Health Crisis and Our Nation's Research Universities
inferred← citeshttps://doi.org/10.1371/journal.pntd.0000680openalex-snapshot
Nuclear Weapons and Neglected Diseases: The “Ten-Thousand-to-One Gap”
inferred← citeshttps://doi.org/10.1371/journal.pntd.0001221openalex-snapshot
Innovative Partnerships for Drug Discovery against Neglected Diseases
inferred← citeshttps://doi.org/10.1371/journal.pntd.0001546openalex-snapshot
Ebola and Marburg Hemorrhagic Fevers: Neglected Tropical Diseases?
inferred← citeshttps://doi.org/10.1371/journal.pntd.0001547openalex-snapshot
A Research Agenda for Helminth Diseases of Humans: Towards Control and Elimination
inferred← citeshttps://doi.org/10.1371/journal.pntd.0001582openalex-snapshot
A Research Agenda for Helminth Diseases of Humans: The Problem of Helminthiases
inferred← citeshttps://doi.org/10.1371/journal.pntd.0001602openalex-snapshot
A Research Agenda for Helminth Diseases of Humans: Health Research and Capacity Building in Disease-Endemic Countries for Helminthiases Control
inferred← citeshttps://doi.org/10.1371/journal.pntd.0001646openalex-snapshot
A Research and Development Agenda for the Control and Elimination of Human Helminthiases
inferred← citeshttps://doi.org/10.1371/journal.pntd.0001750openalex-snapshot
The Impact of the US Priority Review Voucher on Private-Sector Investment in Global Health Research and Development
inferred← citeshttps://doi.org/10.1371/journal.pntd.0001773openalex-snapshot
Determining Treatment Needs at Different Spatial Scales Using Geostatistical Model-Based Risk Estimates of Schistosomiasis
inferred← citeshttps://doi.org/10.1371/journal.pntd.0001845openalex-snapshot
Review of Two Decades of Cholera Diagnostics – How Far Have We Really Come?
inferred← citeshttps://doi.org/10.1371/journal.pntd.0001861openalex-snapshot
Is Chagas Disease Really the “New HIV/AIDS of the Americas”?
inferred← citeshttps://doi.org/10.1371/journal.pntd.0002019openalex-snapshot
Evaluation of the European Foundation Initiative into African Research in Neglected Tropical Diseases by the African Fellows
inferred← citeshttps://doi.org/10.1371/journal.pntd.0002568openalex-snapshot
Canada's Neglected Tropical Disease Research Network: Who's in the Core—Who's on the Periphery?
inferred← citeshttps://doi.org/10.1371/journal.pntd.0003092openalex-snapshot
Current Pipelines for Neglected Diseases
inferred← citeshttps://doi.org/10.1371/journal.pntd.0008002openalex-snapshot
Helminth infections among rural schoolchildren in Southern Ethiopia: A cross-sectional multilevel and zero-inflated regression model
inferred← citeshttps://doi.org/10.1371/journal.pntd.0010809openalex-snapshot
Antibiofilm agents with therapeutic potential against enteroaggregative Escherichia coli
inferred← citeshttps://doi.org/10.1371/journal.pone.0010610openalex-snapshot
Development of and Access to Products for Neglected Diseases
inferred← citeshttps://doi.org/10.1371/journal.pone.0020438openalex-snapshot
Analyzing Media Coverage of the Global Fund Diseases Compared with Lower Funded Diseases (Childhood Pneumonia, Diarrhea and Measles)
inferred← citeshttps://doi.org/10.1371/journal.pone.0056410openalex-snapshot
Characteristics of Randomized Trials Published in Latin America and the Caribbean According to Funding Source
inferred← citeshttps://doi.org/10.1371/journal.pone.0301414openalex-snapshot
Iran’s research prioritization: Are we meeting the goals? A study based on clinical trial registry data
inferred← citeshttps://doi.org/10.1377/hlthaff.28.6.1691openalex-snapshot
Turning Neglected Tropical Diseases Into Forgotten Maladies
inferred← citeshttps://doi.org/10.1377/hlthaff.28.6.1750openalex-snapshot
Spurring New Research For Neglected Diseases
inferred← citeshttps://doi.org/10.1377/hlthaff.28.6.1774openalex-snapshot
Expanding The Biopharmaceutical Industry’s Involvement In Fighting Neglected Diseases
inferred← citeshttps://doi.org/10.1387/theoria.1300openalex-snapshot
How to Make the Research Agenda in the Health Sciences Less Distorted
inferred← citeshttps://doi.org/10.1515/ci.2013.35.3.2openalex-snapshot
Neglected Tropical Diseases in Latin America
inferred← citeshttps://doi.org/10.1517/17460441.2011.573782openalex-snapshot
Methodological advances in drug discovery for Chagas disease
inferred← citeshttps://doi.org/10.1586/eri.11.68openalex-snapshot
Better late than never: antivirals for dengue
inferred← citeshttps://doi.org/10.1596/978-1-4648-0307-9_ch2openalex-snapshot
Global Public Goods and International Development
inferred← citeshttps://doi.org/10.17226/13296openalex-snapshot
Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad
inferred← citeshttps://doi.org/10.19132/1808-5245230.31-49openalex-snapshot
Perfil da produção científica em Medicina Tropical na América Latina: análise do termo “Tropical Medicine” na Web of Science
inferred← citeshttps://doi.org/10.2105/ajph.2011.300325openalex-snapshot
Against the Very Idea of the Politicization of Public Health Policy
inferred← citeshttps://doi.org/10.2143/lea.228.0.3078180openalex-snapshot
Health, Food, and Science
inferred← citeshttps://doi.org/10.2147/dddt.s16381openalex-snapshot
Drug discovery and development for neglected diseases: the DNDi model
inferred← citeshttps://doi.org/10.2174/0929867325666180926151059openalex-snapshot
The Thiol-polyamine Metabolism of Trypanosoma cruzi: Molecular Targets and Drug Repurposing Strategies
inferred← citeshttps://doi.org/10.2174/0929867326666191016114839openalex-snapshot
In Silico Drug Repositioning for Chagas Disease
inferred← citeshttps://doi.org/10.2174/1386207318666150803141219openalex-snapshot
Artificial Neural Network Methods Applied to Drug Discovery for Neglected Diseases
inferred← citeshttps://doi.org/10.2174/1568026616666161025161153openalex-snapshot
The Widespread Anti-Protozoal Action of HIV Aspartic Peptidase Inhibitors: Focus on Plasmodium spp., Leishmania spp. and Trypanosoma cruzi
inferred← citeshttps://doi.org/10.2174/1874279301005010089openalex-snapshot
Supplementary Information on Global and European Funding on HIV/AIDS and M. tuberculosis/TB
inferred← citeshttps://doi.org/10.21825/em.94613openalex-snapshot
Health 2020 en het Innovative Medicines Initiative 2
inferred← citeshttps://doi.org/10.23936/pfr.v5i2.160openalex-snapshot
Social science and the complexity of tropical medicine
inferred← citeshttps://doi.org/10.2471/blt.12.114454openalex-snapshot
Use of data from registered clinical trials to identify gaps in health research and development
inferred← citeshttps://doi.org/10.3109/13880209.2015.1059861openalex-snapshot
Isolation, characterization, and anthelminthic activities of a novel dichapetalin and other constituents ofDichapetalum filicaule
inferred← citeshttps://doi.org/10.3386/w15468openalex-snapshot
Investments in Pharmaceuticals Before and After TRIPS
inferred← citeshttps://doi.org/10.3390/molecules26185676openalex-snapshot
In Vitro Phenotypic Activity and In Silico Analysis of Natural Products from Brazilian Biodiversity on Trypanosoma cruzi
inferred← citeshttps://doi.org/10.3390/molecules29030635openalex-snapshot
Drug Repurposing in the Chemotherapy of Infectious Diseases
inferred← citeshttps://doi.org/10.3390/tropicalmed5020088openalex-snapshot
Funding for Chagas Disease: A 10-Year (2009–2018) Survey
inferred← citeshttps://doi.org/10.3395/reciis.v6i3.600enopenalex-snapshot
Multi-user equipment, core-facilities and technological platforms: the evolution of organizational strategies for translational health research - DOI: 10.3395/reciis.v6i3.600en
inferred← citeshttps://doi.org/10.3402/gha.v6i0.22450openalex-snapshot
The mismatch between the health research and development (R&D) that is needed and the R&D that is undertaken: an overview of the problem, the causes, and solutions
showing the first 200 of 219
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.